Dr. Loretta Pylant Gremillion, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2409 Broadmoor Blvd, Monroe, LA 71201 Phone: 318-323-8799 Fax: 318-323-8815 |
Dr. Kimberly M Mills, M.D. Dermatology - Clinical & Laboratory Dermatological Immunology Medicare: Accepting Medicare Assignments Practice Location: 2804 Forsythe Ave, Monroe, LA 71201 Phone: 318-388-0032 Fax: 318-388-0491 |
Dr. Creighton Chandler Jr., MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 920 Oliver Rd # A, Monroe, LA 71201 Phone: 318-361-2136 Fax: 318-812-6338 |
Ms. Caitlin Gail Robinson, MD Dermatology - MOHS-Micrographic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2408 Duval Dr, Monroe, LA 71201 Phone: 318-516-2711 Fax: 318-516-2711 |
Mrs. Mary Janine O Hopkins, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2509 Broadmoor Blvd, Ste A, Monroe, LA 71201 Phone: 318-325-0600 Fax: 318-325-0890 |
Dr. James Arthur Altick Jr., M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2804 Kilpatrick Blvd, Monroe, LA 71201 Phone: 318-387-2545 Fax: 318-387-2775 |
News Archive
BioLight Life Sciences Investments, a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, today announced that it has expanded its relationship with Ora, Inc., a world-leading independent, full-service ophthalmic contract research organization and product development firm, via the signing of a Collaboration Agreement (the "Agreement") pursuant to which the companies will work together to advance the clinical, regulatory and commercial development of BioLight's TeaRx multi-parameter diagnostic test for dry eye syndrome ("DES").
For all of the promise embryonic stem cells hold for therapies for neurodegenerative diseases such as Parkinson's disease, they are notoriously difficult to use.
Currently, the world generic drug market is approaching $40 billion. Over the next five years, the market is expected to grow 10-15% annually.
A new study reveals that individuals with traumatic brain injury (TBI) have significantly more difficulty with gist reasoning than traditional cognitive tests. Using a unique cognitive assessment developed by researchers at the Center for BrainHealth at The University of Texas at Dallas, findings published Friday in the Journal of Clinical and Experimental Neuropsychology indicate that an individual's ability to "get the gist or extract the essence of a message" after a TBI more strongly predicts his or her ability to effectively hold a job or maintain a household than previously revealed by traditional cognitive tests alone.
In addition, media outlets report that the nation's largest for-profit insurers will not participate in California's online marketplace. Eleven insurers have applied to operate plans in Colorado.
› Verified 1 days ago